The investigators refer to the trial with clinicaltrials.gov indentifier NCT02610933 entitled
Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2
in Hemodialysis Patients.
After termination of this trial, included patients will be asked to participate in the
extension trial by continuing the treament of their respective allocation arm. No new
intervention will be done.
Phase:
Phase 4
Details
Lead Sponsor:
Onze Lieve Vrouw Hospital
Treatments:
Rivaroxaban Vitamin K Vitamin K 2 Vitamin MK 7 Vitamins Warfarin